$1.51 Billion is the total value of ARMISTICE CAPITAL, LLC's 66 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | New | ISHARES TRput | $90,804,000 | – | 6,000 | +100.0% | 6.02% | – |
| EPC | New | EDGEWELL PERS CARE COcall | $48,735,000 | – | 15,000 | +100.0% | 3.23% | – |
| KHC | New | KRAFT HEINZ CO | $41,903,000 | – | 1,500,000 | +100.0% | 2.78% | – |
| ORLY | New | O REILLY AUTOMOTIVE INC NEW | $26,899,000 | – | 67,500 | +100.0% | 1.78% | – |
| VFC | New | V F CORP | $25,362,000 | – | 285,000 | +100.0% | 1.68% | – |
| CMG | New | CHIPOTLE MEXICAN GRILL INC | $25,214,000 | – | 30,000 | +100.0% | 1.67% | – |
| RL | New | RALPH LAUREN CORPcl a | $22,149,000 | – | 232,000 | +100.0% | 1.47% | – |
| WEN | New | WENDYS CO | $19,980,000 | – | 1,000,000 | +100.0% | 1.32% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $19,124,000 | – | 88,000 | +100.0% | 1.27% | – |
| BOLD | New | AUDENTES THERAPEUTICS INC | $17,865,000 | – | 636,000 | +100.0% | 1.18% | – |
| WING | New | WINGSTOP INC | $12,917,000 | – | 148,000 | +100.0% | 0.86% | – |
| ULTA | New | ULTA BEAUTY INC | $11,655,000 | – | 46,500 | +100.0% | 0.77% | – |
| MRK | New | MERCK & CO INC | $11,448,000 | – | 136,000 | +100.0% | 0.76% | – |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $10,821,000 | – | 264,000 | +100.0% | 0.72% | – |
| TSCO | New | TRACTOR SUPPLY CO | $9,768,000 | – | 108,000 | +100.0% | 0.65% | – |
| VXRT | New | VAXART INC | $8,616,000 | – | 24,000,000 | +100.0% | 0.57% | – |
| EYEG | New | EYEGATE PHARMACEUTICALS INC | $8,438,000 | – | 1,792,500 | +100.0% | 0.56% | – |
| TWNK | New | HOSTESS BRANDS INCcl a | $8,111,000 | – | 580,000 | +100.0% | 0.54% | – |
| LB | New | L BRANDS INC | $8,032,000 | – | 410,000 | +100.0% | 0.53% | – |
| AVYA | New | AVAYA HLDGS CORP | $5,320,000 | – | 520,000 | +100.0% | 0.35% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $5,083,000 | – | 30,000 | +100.0% | 0.34% | – |
| URBN | New | URBAN OUTFITTERS INC | $4,775,000 | – | 170,000 | +100.0% | 0.32% | – |
| PTCT | New | PTC THERAPEUTICS INC | $4,600,000 | – | 136,000 | +100.0% | 0.30% | – |
| CPST | New | CAPSTONE TURBINE CORP | $2,670,000 | – | 835,000 | +100.0% | 0.18% | – |
| CTXR | New | CITIUS PHARMACEUTICALS INC | $2,468,000 | – | 2,197,385 | +100.0% | 0.16% | – |
| SPHS | New | SOPHIRIS BIO INC | $2,207,000 | – | 1,793,666 | +100.0% | 0.15% | – |
| BLCM | New | BELLICUM PHARMACEUTICALS INC | $1,087,000 | – | 1,034,962 | +100.0% | 0.07% | – |
| MDGS | New | MEDIGUS LTDsponsored ads | $809,000 | – | 1,285,715 | +100.0% | 0.05% | – |
| AEZS | New | AETERNA ZENTARIS INC | $494,000 | – | 480,000 | +100.0% | 0.03% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.